Dr. Jennifer Lynn Gnerlich, MD

Dr. Gnerlich practices at Lexington Surgery in West Columbia, South Carolina.

Dr. Gnerlich's NPI, 1790872596, was assigned on October 5, 2006. Dr. Gnerlich graduated from University of Chicago, Pritzker School of Medicine in 2004. Dr. Gnerlich holds South Carolina license 90602.

Dr. Gnerlich's primary practice is Lexington Surgery, at 146 E Hospital Dr, West Columbia, SC 29169 in Lexington County. The practice phone is (803) 936-3300.

Dr. Gnerlich's primary practice is Lexington Surgery in West Columbia, South Carolina. The medical group on file is Lexington Orthopaedics and Sports Medicine. Dmand AI also links Dr. Gnerlich to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gnerlich practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Gnerlich's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Gnerlich's licenses on file in 2 states: South Carolina and Virginia.

CMS data shows 202 Medicare services from Dr. Gnerlich across 9 procedure codes in 2024, for 94 Medicare patients. Medicare paid $24,660 for them.

CMS counts 94 Medicare patients who saw Dr. Gnerlich in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gnerlich's median patient age at 66, with 89% women.

In 2024, Dr. Gnerlich wrote 91 Medicare Part D claims for 55 patients. 95% of them were for generic drugs. CMS names the drug for 51 of them, across 1 drug with 11 or more claims each, at $65 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gnerlich for performance year 2024, reported as part of a group.

Dmand AI links 13 papers to Dr. Gnerlich, published from 2010 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Pancreatic Neoplasms, Breast Neoplasms and Adenocarcinoma. Dr. Gnerlich has published most often in Ann Surg Oncol. Dr. Gnerlich's most frequent co-authors are Bernard John Dubray, MD, David C. Linehan, MD and Joshua Samuel Weir, DO, MBA, MS.

Dmand AI links Dr. Gnerlich to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases.

CMS Open Payments shows 36 general payments to Dr. Gnerlich from 21 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 66% of the total. Celgene Corporation paid the most, $1,426.

Dr. Gnerlich graduated from University of Chicago, Pritzker School of Medicine in 2004.